Sinopharm And Gansu Government Sign Strategic Cooperation Agreement
This article was originally published in PharmAsia News
Executive Summary
Sinopharm and the Gansu Provincial Party Committee Secretary recently signed a strategic cooperation framework agreement, which will increase investment in Gansu's drug industry. Under the agreement Sinopharm will cooperate in the construction of a traditional Chinese medicine production and processing center, speed up construction of a drug logistics and distribution network, participate in the reorganization of Gansu drug companies, and aid in pharmaceutical industry development planning. Secretary Lu Hao said Gansu province is not only rich in Chinese herbal medicine resources, but also possesses industrial advantages that create potential for pharmaceutical industry development. (Click Here For More - Chinese Language
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.